Deep learning analysis of magnetic resonance imaging accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis

Yashbir Singh, John E. Eaton, Sudhakar K. Venkatesh, Christopher L. Welle, Byron Smith, Shahriar Faghani, Mette Vesterhus, Tom H. Karlsen, Kristin K. Jorgensen, Trine Folseraas, Kosta Petrovic, Anne Negard, Ida Bjoerk, Andreas Abildgaard, Aliya F. Gulamhusein, Kartik Jhaveri, Gregory J. Gores, Sumera I. Ilyas, Timucin Taner, Julie K. HeimbachTy S. Diwan, Nicholas F. Larusso, Konstantinos N. Lazaridis, Bradley J. Erickson

Research output: Contribution to journalArticlepeer-review

Abstract

Background and aims: Among those with primary sclerosing cholangitis (PSC), perihilar CCA (pCCA) is often diagnosed at a late-stage and is a leading source of mortality. Detection of pCCA in PSC when curative action can be taken is challenging. Our aim was to create a deep learning model that analyzed magnetic resonance imaging (MRI) to detect early-stage pCCA and compare its diagnostic performance with expert radiologists. Approach and results: We conducted a multicenter, international, retrospective cohort study involving adults with large duct PSC who underwent contrast-enhanced MRI. Senior abdominal radiologists reviewed the images. All patients with pCCA had early-stage cancer and were registered for liver transplantation. We trained a 3D DenseNet-121 model, a form of deep learning, using MRI images and assessed its performance in a separate test cohort. The study included 398 patients (training cohort n=150; test cohort n=248). pCCA was present in 230 individuals (training cohort n=64; test cohort n=166). In the test cohort, the respective performances of the model compared to the radiologists were: sensitivity 87.9% versus 50.0%, p<0.001; specificity 84.1% versus 100.0%, p<0.001; area under receiving operating curve 86.0% versus 75.0%, p<0.001. Even when a mass was absent, the model had a higher sensitivity for pCCA than radiologists (91.6% vs. 50.6%, p<0.001) and maintained good specificity (84.1%). Conclusion: The 3D DenseNet-121 MRI model effectively detects early-stage pCCA in PSC patients. Compared to expert radiologists, the model missed fewer cases of cancer.

Original languageEnglish (US)
Article number10.1097/HEP.0000000000001314
JournalHepatology
DOIs
StateAccepted/In press - 2025

Keywords

  • artificial intelligence
  • cancer
  • convolutional neural network
  • deep learning
  • diagnosis

ASJC Scopus subject areas

  • Hepatology

Fingerprint

Dive into the research topics of 'Deep learning analysis of magnetic resonance imaging accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis'. Together they form a unique fingerprint.

Cite this